Pharma Archives - Page 8 of 68 - Life Sciences Times

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

June 6, 2025

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

June 5, 2025

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

June 4, 2025

THIS WEEK'S STORIES

Konovo Appoints Tim Albury as Chief Financial Officer to Support Growth of AI-Driven Healthcare Platform

June 4, 2025

Acerand Therapeutics Begins First-in-Human Trial of ACE-232 for Advanced Prostate Cancer

June 5, 2025

CinDome Pharma Begins Phase 2 Trial of Deudomperidone for Idiopathic Gastroparesis

June 4, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Vertex Highlights Potential of ALYFTREK in Cystic Fibrosis at European Conference

Otsuka’s Sibeprenlimab Shows Strong Results in Phase 3 Trial for IgA Nephropathy

Mediar Therapeutics Begins Phase 2 Trial of MTX-463 for Idiopathic Pulmonary Fibrosis

Acerand Therapeutics Begins First-in-Human Trial of ACE-232 for Advanced Prostate Cancer

Seyltx Reports Promising Preclinical Results for Chronic Cough Drug Ifenprodil Ahead of Phase 2 Trials

Most Read

AI-Powered Tool Set to Revolutionize Type 1 Diabetes Diagnosis and Treatment

ZEISS CLARUS 700 Retinal Imaging System Receives Approval in China

Vera Whole Health and Anthem Expand Primary Care Access in Richmond Amid Physician Shortage

New GI Alliance Surgery Center and Clinic Opens in Bentonville

EDITOR PICKS

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

THIS WEEK'S STORIES

Konovo Appoints Tim Albury as Chief Financial Officer to Support Growth of AI-Driven Healthcare Platform

Acerand Therapeutics Begins First-in-Human Trial of ACE-232 for Advanced Prostate Cancer

CinDome Pharma Begins Phase 2 Trial of Deudomperidone for Idiopathic Gastroparesis

POPULAR CATEGORY

ABOUT US

FOLLOW US